Intellia Therapeutics (NTLA) Treasury Shares (2015 - 2026)

Intellia Therapeutics (NTLA) has 12 years of Treasury Shares data on file, last reported at $6.3 million in Q1 2026.

• Quarterly Treasury Shares rose 13.83% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (up 13.83% YoY) and the FY2025 annual result came in at $5.2 million, down 6.33% from the prior year.
• Treasury Shares grew to $6.3 million in Q1 2026 per NTLA's latest filing, from $5.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $6.3 million in Q1 2026 and bottomed at $1.4 million in Q1 2022.
• The 5-year median for Treasury Shares is $5.2 million (2025), against an average of $4.3 million.
• The widest annual swing landed in 2022, when Treasury Shares jumped 334.88%; it then declined 6.33% in 2025.
• Tracing NTLA's Treasury Shares over 5 years: stood at $1.9 million in 2022, then soared by 108.19% to $4.0 million in 2023, then soared by 37.26% to $5.5 million in 2024, then fell by 6.33% to $5.2 million in 2025, then climbed by 21.05% to $6.3 million in 2026.
• Per Business Quant, the three latest NTLA Treasury Shares figures stand at $6.3 million (Q1 2026), $5.2 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison